These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9414118)

  • 1. Proteolytic processing of presenilin-1 (PS-1) is not associated with Alzheimer's disease with or without PS-1 mutations.
    Okochi M; Ishii K; Usami M; Sahara N; Kametani F; Tanaka K; Fraser PE; Ikeda M; Saunders AM; Hendriks L; Shoji SI; Nee LE; Martin JJ; Van Broeckhoven C; St George-Hyslop PH; Roses AD; Mori H
    FEBS Lett; 1997 Nov; 418(1-2):162-6. PubMed ID: 9414118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex.
    Capell A; Grünberg J; Pesold B; Diehlmann A; Citron M; Nixon R; Beyreuther K; Selkoe DJ; Haass C
    J Biol Chem; 1998 Feb; 273(6):3205-11. PubMed ID: 9452432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease associated presenilin-1 holoprotein and its 18-20 kDa C-terminal fragment are death substrates for proteases of the caspase family.
    Grunberg J; Walter J; Loetscher H; Deuschle U; Jacobsen H; Haass C
    Biochemistry; 1998 Feb; 37(8):2263-70. PubMed ID: 9485372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of Alzheimer-associated mutations of presenilin 1 on its processing.
    Murayama O; Honda T; Mercken M; Murayama M; Yasutake K; Nihonmatsu N; Nakazato Y; Michel G; Song S; Sato K; Takahashi H; Takashima A
    Neurosci Lett; 1997 Jun; 229(1):61-4. PubMed ID: 9224802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic fragments of the Alzheimer's disease associated presenilins-1 and -2 are phosphorylated in vivo by distinct cellular mechanisms.
    Walter J; Grünberg J; Schindzielorz A; Haass C
    Biochemistry; 1998 Apr; 37(17):5961-7. PubMed ID: 9558331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue.
    Podlisny MB; Citron M; Amarante P; Sherrington R; Xia W; Zhang J; Diehl T; Levesque G; Fraser P; Haass C; Koo EH; Seubert P; St George-Hyslop P; Teplow DB; Selkoe DJ
    Neurobiol Dis; 1997; 3(4):325-37. PubMed ID: 9173929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic processing of Alzheimer's disease associated proteins.
    Haass C; Grünberg J; Capell A; Wild-Bode C; Leimer U; Walter J; Yamazaki T; Ihara I; Zweckbronner I; Jakubek C; Baumeister R
    J Neural Transm Suppl; 1998; 53():159-67. PubMed ID: 9700654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired proteolytic processing of presenilin-1 in chromosome 14-linked familial Alzheimer's disease patient lymphocytes.
    Takahashi H; Mercken M; Honda T; Saito Y; Murayama M; Song S; Takashima A
    Neurosci Lett; 1999 Jan; 260(2):121-4. PubMed ID: 10025714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation.
    Steiner H; Capell A; Pesold B; Citron M; Kloetzel PM; Selkoe DJ; Romig H; Mendla K; Haass C
    J Biol Chem; 1998 Nov; 273(48):32322-31. PubMed ID: 9822712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase C.
    Walter J; Grünberg J; Capell A; Pesold B; Schindzielorz A; Citron M; Mendla K; George-Hyslop PS; Multhaup G; Selkoe DJ; Haass C
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5349-54. PubMed ID: 9144240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homodimerization of presenilin N-terminal fragments is affected by mutations linked to Alzheimer's disease.
    Cervantes S; Gonzàlez-Duarte R; Marfany G
    FEBS Lett; 2001 Sep; 505(1):81-6. PubMed ID: 11557046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of presenilin 1 and presenilin 2 expression and processing by newly developed monoclonal antibodies.
    Diehlmann A; Ida N; Weggen S; Grünberg J; Haass C; Masters CL; Bayer TA; Beyreuther K
    J Neurosci Res; 1999 May; 56(4):405-19. PubMed ID: 10340748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zebrafish (Danio rerio) presenilin promotes aberrant amyloid beta-peptide production and requires a critical aspartate residue for its function in amyloidogenesis.
    Leimer U; Lun K; Romig H; Walter J; Grünberg J; Brand M; Haass C
    Biochemistry; 1999 Oct; 38(41):13602-9. PubMed ID: 10521267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing.
    Baumeister R; Leimer U; Zweckbronner I; Jakubek C; Grünberg J; Haass C
    Genes Funct; 1997 Apr; 1(2):149-59. PubMed ID: 9680315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios.
    Walker ES; Martinez M; Brunkan AL; Goate A
    J Neurochem; 2005 Jan; 92(2):294-301. PubMed ID: 15663477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies: Evidence that Alzheimer mutations affect proteolytic processing.
    Mercken M; Takahashi H; Honda T; Sato K; Murayama M; Nakazato Y; Noguchi K; Imahori K; Takashima A
    FEBS Lett; 1996 Jul; 389(3):297-303. PubMed ID: 8766720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease.
    Mathews PM; Cataldo AM; Kao BH; Rudnicki AG; Qin X; Yang JL; Jiang Y; Picciano M; Hulette C; Lippa CF; Bird TD; Nochlin D; Walter J; Haass C; Lévesque L; Fraser PE; Andreadis A; Nixon RA
    Mol Med; 2000 Oct; 6(10):878-91. PubMed ID: 11126202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of detergent-insoluble complexes containing the familial Alzheimer's disease-associated presenilins.
    Parkin ET; Hussain I; Karran EH; Turner AJ; Hooper NM
    J Neurochem; 1999 Apr; 72(4):1534-43. PubMed ID: 10098859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxyl-terminal fragments of presenilin-1 are closely related to cytoskeletal abnormalities in Alzheimer's brains.
    Tomidokoro Y; Ishiguro K; Igeta Y; Matsubara E; Kanai M; Shizuka M; Kawarabayashi T; Harigaya Y; Kawakatsu S; Ii K; Ikeda M; St George-Hyslop PH; Hirai S; Okamoto K; Shoji M
    Biochem Biophys Res Commun; 1999 Mar; 256(3):512-8. PubMed ID: 10080929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperaccumulation of FAD-linked presenilin 1 variants in vivo.
    Lee MK; Borchelt DR; Kim G; Thinakaran G; Slunt HH; Ratovitski T; Martin LJ; Kittur A; Gandy S; Levey AI; Jenkins N; Copeland N; Price DL; Sisodia SS
    Nat Med; 1997 Jul; 3(7):756-60. PubMed ID: 9212102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.